Literature DB >> 34258485

Endovascular repair of a common femoral artery puncture after losing access using a vascular closure device.

Vamsi Reddy1, Nathan Todnem2, Camila Franco-Mesa3, Young Erben3, Rabih G Tawk4, Charles Ritchie5.   

Abstract

We present a case of a common femoral artery repair after losing access to the vessel in a 67-year-old woman using a Mynx-Grip vascular closure device. The hematoma over the right common femoral artery was accessed under fluoroscopic guidance. Then, the balloon of the closure device was inflated inside the artery and pulled back against the origin of the puncture site into the common femoral artery. Finally, the collagen plug was deployed and pressed against the outside of the vessel to occlude the puncture site.
© 2021 The Author(s).

Entities:  

Keywords:  Endovascular, Common femoral artery, Vascular closure

Year:  2021        PMID: 34258485      PMCID: PMC8259393          DOI: 10.1016/j.jvscit.2021.04.026

Source DB:  PubMed          Journal:  J Vasc Surg Cases Innov Tech        ISSN: 2468-4287


Iatrogenic common femoral artery pseudoaneurysm is a common complication and occurs in 0.1% to 0.2% of diagnostic angiograms and 3.5% to 5.5% of interventional procedures. Although this rate has remained stable, the overall incidence has increased owing to an increase in endovascular procedures within the past decade. Various surgical and nonsurgical treatment modalities have been used to treat pseudoaneurysms including ultrasound-guided thrombin injection, compression devices and endovascular stent placement.3, 4, 5, 6 Herein, we present an alternative technique using a Mynx-Grip vascular closure device (CardinalHealth, Dublin, Ohio) for the management of vessel hemorrhage immediately after the loss of intravascular access and before leaving the endovascular suite to present the formation of the pseudoaneurysm at the access site vessel. Informed consent was obtained from the patient for this publication.

Case report

A 67-year-old woman presented to our tertiary care center for treatment of a small basilar artery aneurysm. The patient was started on aspirin and clopidogrel for stent assisted coiling of the aneurysm. A 5F 10-cm sheath was inserted into the right common femoral artery. During the exchange from the 5F to a 6F 80-cm guide sheath, access to the right common femoral artery was lost and the 6F guide sheath was dislodged superiorly and medially within the soft tissue. Manual pressure was held over the right common femoral artery access site while new access through the left common femoral artery was obtained. An angiogram of the right common femoral artery demonstrated a large hematoma with contrast extravasation (Fig 1). Despite 40 minutes of manual pressure held over the right common femoral artery, the hemorrhage persisted. The dome of the hematoma was accessed through the original access site under ultrasound and fluoroscopic roadmap guidance using a 21G micropuncture needle and a microwire. A 6F, 10-cm sheath was inserted through the hematoma into the common femoral artery (Fig 2, A). Once the sheath location was confirmed within the right common femoral artery, a Mynx-Grip closure device was inserted into the sheath (Fig 2, B). The balloon was inflated inside the artery and pulled back against the origin of the puncture and contrast extravasation site. A right femoral artery angiogram was performed demonstrating exclusion of the hemorrhage by the balloon of the closure device. The sheath was pulled out and the collagen plug was deployed and pressed against the outside the vessel to obliterate the puncture site. A final angiogram demonstrated complete obliteration of the puncture site with no evidence of extravasation or vessel dissection (Fig 2, C). On follow-up 3 months after the index procedure, the patient does not demonstrate any signs of infection. Duplex ultrasound imaging demonstrates no pseudoaneurysm, dissection, or arteriovenous fistula formation.
Fig 1

Angiogram after lost access demonstrating a large pseudoaneurysm with contrast extravasation (White arrow is the 6F guide sheath adjacent to the artery).

Fig 2

(A) Anterior-posterior and lateral views of percutaneous access to the common femoral artery through the pseudoaneurysm with a micropuncture needle and microwire. (B) Anterior-posterior and lateral views demonstrating inflation of the Mynx-Grip closure device balloon at the pseudoaneurysm site. (C) Final angiogram demonstrating no evidence of residual pseudoaneurysm or contrast extravasation.

Angiogram after lost access demonstrating a large pseudoaneurysm with contrast extravasation (White arrow is the 6F guide sheath adjacent to the artery). (A) Anterior-posterior and lateral views of percutaneous access to the common femoral artery through the pseudoaneurysm with a micropuncture needle and microwire. (B) Anterior-posterior and lateral views demonstrating inflation of the Mynx-Grip closure device balloon at the pseudoaneurysm site. (C) Final angiogram demonstrating no evidence of residual pseudoaneurysm or contrast extravasation.

Discussion

The treatment options for iatrogenic pseudoaneurysms are diverse and include a wide range of options from the simple application of pressure over the pseudoaneurysm area to surgical management in complicated cases. Advances in endovascular technology allowed the development of alternative off-label methods to target vascular repairs in a less invasive manner. Devices such as the Mynx-Grip typically used for arteriotomy closures, can be safely used in cases in which loss of access has taken place for hemorrhage control and arterial access closure. When Azmoon et al evaluated the rate of hemostasis after vascular closure after percutaneous coronary intervention with Mynx-Grip devices, vascular complications occurred in 2.1% of 190 patients. We emphasize in this case report the use of fluoroscopic and ultrasound techniques to access the previously lost arterial access site in adjunctive manner to obtain vascular control., Other management techniques for the loss of access and hemorrhagic event includes active pressure over the puncture site, placement of a covered stent, prolonged balloon angioplasty, and direct surgical cut-down of the vessel.11, 12, 13 To the best of our knowledge, this alternative closure technique is only possible owing to the dual action of this specific closure device. The intravascular balloon prevents slipping of this device while limiting the hemorrhage; the sealant that is deployed in the outside of the vessel provides the needed agents for thrombosis. There is no similar use of the Mynx-Grip device to repair an arterial puncture complication through access loss by re-accessing the femoral artery through the hematoma and obtaining hemorrhage control using this closure device. This alternative strategy is an appealing option for providers who are familiar with this closure device and should remain in the armamentarium of vascular interventionists.

Conclusions

This technical case report demonstrates an alternative and effective technique that can be used in the management of iatrogenic arterial access site loss with hemorrhage. Vascular closure devices such as the Mynx-Grip are frequently used with fairly low complication rates. Physicians performing endovascular interventions who are familiar with this closure device can consider this off-label technique to avoid the possible need for stent placement or an open repair of the vessel in question.
  12 in total

1.  Routine Ultrasound or Fluoroscopy Use and Risk of Vascular/Bleeding Complications After Transfemoral TAVR.

Authors:  Guy Witberg; Vasileios Tzalamouras; Heath Adams; Tiffany Patterson; Ross Roberts-Thomson; Jonathan Byrne; Rafal Dworakowski; Philip MacCarthy; Simon Redwood; Bernard Prendergast
Journal:  JACC Cardiovasc Interv       Date:  2020-06-22       Impact factor: 11.195

2.  Use of a pneumatic compression system (FemoStop) as a treatment option for femoral artery pseudoaneurysms after percutaneous cardiac procedures.

Authors:  G Dangas; R Mehran; S Duvvuri; J A Ambrose; S K Sharma
Journal:  Cathet Cardiovasc Diagn       Date:  1996-10

Review 3.  Diagnosis and treatment of iatrogenic femoral artery pseudoaneurysm: a review.

Authors:  I Kronzon
Journal:  J Am Soc Echocardiogr       Date:  1997-04       Impact factor: 5.251

4.  Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device.

Authors:  Shah Azmoon; Anthony L Pucillo; Wilbert S Aronow; Ramin Ebrahimi; Joseph Vozzolo; Archana Rajdev; Kumar Kalapatapu; Jae H Ro; Craig Hjemdahl-Monsen
Journal:  J Invasive Cardiol       Date:  2010-04       Impact factor: 2.022

5.  Treatment of a recurrent false aneurysm of the femoral artery by stent--graft placement from the brachial artery.

Authors:  Yuki Orimoto; Jasper W van Keulen; Evert J Waasdorp; Frans L Moll; Joost A van Herwaarden
Journal:  Ann Vasc Surg       Date:  2011-05-28       Impact factor: 1.466

6.  An Iatrogenic Femoral Artery Pseudoaneurysm Caused by Endovascular Stenting for the Treatment of Anastomotic Stenosis: An Unusual Complication and its Successful Surgical Management.

Authors:  Yusuf Velioglu; Ahmet Yuksel
Journal:  J Coll Physicians Surg Pak       Date:  2019-09       Impact factor: 0.711

7.  Mynx Vascular Closure Device in Arterial Endovascular Procedures.

Authors:  Michael C Scott; Horace J Spencer; Ahsan T Ali; Mohammed M Moursi; Guillermo A Escobar; Lewis C Lyons; Matthew R Smeds
Journal:  Ann Vasc Surg       Date:  2017-05-22       Impact factor: 1.466

8.  Ultrasound-Guided Fibrin Glue Injection for Treatment of Iatrogenic Femoral Pseudoaneurysms.

Authors:  Maria Gummerer; Moritz Kummann; Alexandra Gratl; Daniela Haller; Andreas Frech; Josef Klocker; Gustav Fraedrich; Hannes Gruber
Journal:  Vasc Endovascular Surg       Date:  2020-06-19       Impact factor: 1.089

9.  Endovascular management of femoral access-site and access-related vascular complications following percutaneous coronary interventions (PCI).

Authors:  Nadjib Schahab; Refik Kavsur; Thorsten Mahn; Christian Schaefer; Alexander Kania; Rolf Fimmers; Georg Nickenig; Sebastian Zimmer
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.